Influence of single and sequential cytokine therapy on the cell cycle of pressure ulcer fibroblastsa

Journal of Applied Research

Volumn 2, Issue 1, 2002, Pages

  Vande Berg, Jerry S ^a,b   Smith, Paul D ^c   Haywood Reid, Patricia L ^a   Munson, Alivia B ^a   Bradley, Nicole R ^a   Robson, Martin C ^c  

^a Medical Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Cell cycle; Chronic wounds; p21; PCNA; Senescence

Indexed keywords

EID: 52449129011     PISSN: 1537064X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Robson MC, Phillips LG, Thomason A, et al: Platelet derived growth factor-BB in chronic pressure ulcers. Lancet 339:23-25, 1992.
2. Mustoe TA. Cutler NR, Allman RM, et al: A phase II study to evaluate recombinant PDGF-BB in the treatment stage III/IV pressure ulcers. Arch Surg 129:213-219, 1994.
3. Rees RS, Robson MC, Smiell SM, et al: Becaplermin gel in the treatment of pressure ulcers: A phase II randomized, double-blind, placebo-controlled study. Wound Rep Reg 7(3):141-147. 1999.
4. Pierce GF. Tarpley JE. Allman RM. et al: Tissue repair processes in healing chronic pressure ulcers treated with recombinant platelet derived growth factor BB. Am J Pathol 145:1399-1410, 1994.
5. Robson MC, Abdullah A. Burns BF. et al: S. Safety and effect of the topical recombinant human interleukin-lb in the management of pressure sores. Wound Rep Reg 2:177-181, 1994.
6. Kucukcelebi A. Hui PS. Sahara K, et al: The effect of interleukin-1 b on the inhibition of contraction of excisional wounds caused by bacterial contamination. Surg Forum 43:715-716, 1992.
7. Kucukcelebi A. Carp SS, Hayward PC, et al: Granulocyte-macrophage colony stimulating factor reverses the inhibition of wound contraction caused by bacterial contamination. Wounds 4:241-247, 1992.
8. Hayward PG. Hokanson J, Meggers JP, et al: Fibroblast growth factor reverses the bacterial retardation of wound contraction. Am J Surg 163:288-293, 1992.
9. Robson MC, Hill DP, Smith PD, et al: Sequential cytokine therapy for pressure ulcers: Clinical and mechanistic response. Ann Surg 231 (4):600-611,2000.
10. Smith JR, Pereira-Smith OM, Braunschweiger Kl. et al: A general method for determining the replicative age of normal animal cell cultures. Mech Aging Devel 12:355-365, 1980.
11. Resch CS, Kerner E, Heggers JP, Scherer M. et al: Pressure sore volume measurement: A technique to document and record wound healing. J Am Geriatr Soc 36:444-446, 1988.
12. Robson MC: Infection in the surgical patient: An imbalance in normal equilibrium. Clin Plast Surg 6:493-503, 1979.
13. Atropoulos MJ, Williams CM: Proliferation markers. Exp Toxic Pathol 48:175-181, 1996.
14. Pardee AB: Gl events and regulation of cell proliferation. Science 246:603-608, 1989.
15. Vande Berg JS, Rudolph R, Hollan C, et al: Fibroblast senescence in pressure ulcers. Wound Rep Reg 6:38-49, 1998.
16. Vande Berg JS, Smith PD, Haywood-Reid PL, et al: Dynamic forces in the cell cycle affecting fibroblasts in pressure ulcers. Wound Rep Reg 9:19-27, 2001.
17. Verrier B, Muller D, Bravo R, Muller R: Wounding a fibroblast monolayer results in the rapid induction of the c-fos proto-oncogene. EMBOJ5(5):913-917, 1986.
18. Rao SS, Kohtz DS: Positive and negative regulation of D-type cyclin expression in skeletal myoblasts by basic fibroblast growth factor and transforming growth factor B. A role for cyclin D-l in control of myoblast differentiation. J Biol Chem 270:4093-4100, 1993.
19. Campisi J: Replicative senescence and immortalization, in Stein GS, Baserga R, Giordano G. Denhardt D (eds): The Molecular Basis of Cell Cycle and Growth Control. New York, Wiley-Liss Inc., pp 348-373, 1999.